Search Thermo Fisher Scientific
ASM Microbe 2023
Tradeshow
Jun 16, 2023
- Jun 18, 2023
George R. Brown Convention Center | Houston, Texas, USA
Join us at Thermo Fisher Scientific Booth #1300 at ASM Microbe 2023 in Houston, TX
We’re ready to empower your expertise with innovative solutions for infectious diseases to boost workflow efficiency, fight antimicrobial resistance (AMR) and guide effective outcomes.
Stop by to see our latest solutions for AI-enabled automated culture plate reading and reporting, antimicrobial susceptibility testing (AST), and molecular diagnostic testing for microbial pathogen detection. And, learn more about:
Automatic removal of negative culture plates from the microbiology workflow via AI and machine learning.
Battling AMR and guiding the best therapeutic decisions with definitive MIC results and the latest antimicrobials for antimicrobial susceptibility testing (AST).
Growing your testing capabilities with real-time PCR solutions to enable early, accurate detection of infectious disease pathogens.
Our microbiome and wastewater workflows enable automated isolation of DNA and RNA from various sample types for use in pathogen detection, qPCR, digital PCR metagenomics, transcriptomics, or other NGS applications.
Custom Commerical Supply for assay development
Whether you are developing a diagnostic or life science solution, access high-quality raw materials and secure chains with Custom Commercial Supply. Our team is here to help you speed up your development and bring your solutions to market faster. Learn more here ›
Register for our showcases and workshops
Utilizing Sensititre to Optimize Patient Outcomes and Promote Antimicrobial Stewardship
Friday, June 16, 12:00pm - 12:45pm | Exhibit Hall, Industry and Science Showcase, Theater B
Speaker: Jerod Nagel, PharmD, BCPS (AQID), Clinical Specialist, Infectious Diseases, University of Michigan Hospital and Health Systems
Priorities for selecting optimal identification and susceptibility testing platforms range from reliability of accurate results, to optimized workflows that minimize redundancy, and facilitation of key antimicrobial stewardship initiatives, including the reduced utilization of antibiotics more likely to promote resistance or cause collateral damage, the identification of clinical options for de-escalation to narrow spectrum agents, and timely therapeutic considerations for multi-drug resistant organisms and/or agents that facilitate outpatient parenteral antimicrobial therapy (OPAT). Through the presentation of case studies, a review of custom automated susceptibility testing solutions and considerations in susceptibility testing reporting, learn more about the multidisciplinary approach to patient management at a large teaching hospital.
Can an Automated Plate Reading System for Urine Cultures Create a More Efficient Laboratory Workflow?
Saturday, June 17, 1:00pm - 1:45pm | Exhibit Hall, Industry and Science Showcase, Theater A
Speaker: Mary George, Ph.D., D. (ABMM), Director Microbiology Lab, Department of Pathology and Laboratory Medicine, Albany Med Health System
Chronic staffing shortages along with increased workload have led many microbiology laboratories to consider automation. While this seems like a practical approach, there are many important considerations in making such a decision including cost, space, accuracy, ease of use and compatibility with already established lean workflows. Hear more about a laboratory’s experience with laboratory automation, determination of how an automated culture plate reading system would allow for more efficient evaluation and reporting of urine cultures, and potential impacts on quality improvements.
Emerging Trends in the Diagnosis and Management of UTIs: Technical and Policy Considerations
Thursday, June 15, 11:00am - 11:45am | Room 351, George R. Brown Convention Center
Speakers:
- Jami Elliot, Chief Executive Officer Quantigen Biosciences
- Manish Patel, MD, RPh, FACS, FPMRS – Chief Medical Officer & Medical Director Vikor Scientific
- Rebecca Schorr, MPH - Manager Health Economics & Outcomes Research & Reimbursement Thermo Fisher Scientific
Moderator:
- Evan Diamond, Director, Business Development, Thermo Fisher Scientific
Molecular testing has made several inroads in the diagnosis pathway for urinary tract infections (UTIs), and numerous clinical management and policy considerations have emerged to challenge the standard of care. While technology advances, clinical guidelines and reimbursement policy are slow to keep pace, and the use of these advancements has expanded beyond clinical utility evidence in peer-reviewed literature. Novel strategies to make data-driven decisions will drive reimbursement determination, and evidence generation to support the clinical utility arguments for molecular diagnostics in UTI are essential. When choosing a molecular test, there are several factors to consider including the intended patient population type, which organisms should be tested, and how faster results can drive value-based healthcare.
Learning objectives:
What are drawbacks of standard urine culture alone, and advantages of molecular technologies in UTI diagnosis.
Considerations when choosing a molecular test.
What’s required to support clinical utility and advance coverage policy.
Emerging Techniques in Microbiome Research and Wastewater Surveillance
Thursday, June 15, 1:00pm – 1:45pm | Room 351 at the Convention Center
Speaker: Huntley Polanshek
Moderator: Heather Martinez, Senior Manager Product Management
Microbiome research and wastewater surveillance are two fields that present challenges in nucleic acid isolation and necessitate the development of novel techniques. Wastewater surveillance has emerged as an effective method to predict and monitor the presence and spread of viruses. However, the large volumes required have hindered the ability to automate wastewater processing. Microbiome samples such as stool, soil, skin swabs, and breastmilk present their own unique challenges, including the presence of PCR inhibitors and tough microbes that require innovative lysis methods. In this workshop, we will cover workflows and best practices for wastewater and microbiome research, including automated concentration and nucleic acid isolation methods. Applications demonstrated will include RT-qPCR, digital PCR and metagenomics. New data showcasing the utility of our workflows for surveillance and monitoring of viruses, fungi, and bacteria in fresh and saltwater will be included, as we expand beyond SARS-CoV-2 surveillance.
Learning objectives:
- Understand the workflows available to concentrate and isolate nucleic acids from wastewater, fresh and salt water for infectious disease surveillance and monitoring.
- Learn about methods and best practices for microbiome research with challenging samples like stool, skin swabs, breastmilk and soil.
Utilizing Molecular Technologies to Drive Productivity in the Microbiology Lab
Thursday, June 15, 10:00am - 10:45am | Room 351, George R. Brown Convention Center
Speaker: Scott E. Brady, CEO and Founder, Wise Diagnostic Systems
Shifting from or supplementing traditional cultures by offering PCR infectious disease testing can be challenging for a laboratory. The addition of this testing is not just a change for the lab, but also for the ordering physicians used to conventional methods. However, that also offers an opportunity to add value to your customers and your lab if you focus on answering three basic questions: Is it good science? Will they use it? And will you get paid? The goal of this presentation is to help answer those questions and to aid in developing practical strategies when on boarding this technology through the example of Wise Diagnostic Systems.
Scientific posters
Can an Automated Plate Reading System for Urine Cultures Create a More Efficient Laboratory Workflow?Friday, June 16, 10:00am - 5:00pm Poster number: P032 |
Cross-sectional Viral Load Distributions can provide an early detection signal for the spread of Influenza viruses in communitiesSaturday, June 17, 10:00am - 5:00pm Poster number: 5439 |
Clinical Performance Comparison Study of Two Multiplex Real-time PCR Kits for Common Enteric Bacterial Pathogen DetectionSunday, June 18, 10:00am - 5:00pm Poster number: 4233 |
Expanded PCR Panel for Uropathogen Identification and Treatment Recommendations in Urinary Tract InfectionsSunday, June 18, 10:00am - 5:00pm Poster number: 4479
|
Products and services featured in the booth
Clever Culture Systems APAS Independence Instrument*
Free up FTE resources with the APAS® Independence, an innovative in vitro diagnostic instrument for automated imaging, analysis and interpretation of agar culture plates. It utilizes the breakthrough Automated Plate Assessment System (APAS) imaging technology and AI algorithms to analyze an image of agar plates, categorizing them as ‘significant growth’, ‘non-significant’ or ‘negative growth’, and ‘for review’.
Sensititre Antimicrobial Susceptibility Testing System*
The Sensititre System provides accurate minimum inhibitory concentration (MIC) results and scalable instrumentation options to support laboratories, clinicians, and pharmacists in the fight against antimicrobial resistance. Help to achieve the best possible clinical outcomes for today’s most critically-ill patients and protect new antimicrobials and last-resort therapies for future generations.
TrueMark™ STI Select Panel Combo Kit†
The Applied Biosystems TrueMark STI Select Panel Combo Kit is a multiplex real‐time PCR solution that contains the assay and master mix needed for the simultaneous detection of RNA from Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma genitalium (MG), and Trichomonas vaginalis (TV) in extracted human samples. Human ribonuclease P (RNase P) is included as endogenous sample collection control.
HIV-1 Genotyping Kit with Integrase†
The Applied Biosystems HIV-1 Genotyping Kit with Integrase is designed to genotype the protease, reverse transcriptase (RT), and integrase (IN) regions of the HIV-1 pol gene. The genotyping result encompasses codons 6-99 in the PR region, codons 1-251 in the RT region, and codons 1-288 of the IN region of the gene. HIV-1 genomic mutations in these regions confer resistance to anti-retroviral drugs that act through the inhibition of the protease and reverse transcriptase.
TaqMan™ PGx Express Panel†
This TaqMan PGx (Pharmacogenomics) Express Panel is offered in pre-spotted 384-well plates, an efficient, easy-to-use format for pharmacogenomics applications. The TaqMan PGx Express Panel contains 64 TaqMan DME and SNP genotyping assays per 384-well plate. The assays were developed to detect polymorphisms in genes encoding drug metabolism enzymes (DMEs) and associated transport proteins. This panel provides coverage of essential, commonly studied markers within CYP2D6, CYP2C9, CYP2C19, and other important DME and clinical research genes.
QuantStudio 5 Dx Real-Time PCR System*
Providing premium performance at an affordable price, the QuantStudio 5 Dx system is designed to fit seamlessly into your existing clinical workflow to help maximize productivity and results.
Lyo-ready Bst DNA Polymerase†
Invitrogen Lyo-ready Bst DNA Polymerase is a proprietary mutant of Bst DNA polymerase, large fragment, with a fast reaction speed and increased sensitivity and tolerance to inhibitors. It is a glycerol-free enzyme, enabling assay lyophilization and use in microfluidics-based technologies.
KingFisher Apex System†
The KingFisher Apex can gently and efficiently isolate and purify nucleic acids, proteins, and cells from a range of sample types for a wide variety of downstream applications. Common applicaitons include: microbial samples, viral/pathogen samples, and wastewater, sewage & sludge
MagMAX™ Microbiome Ultra Nucleic Acid Isolation Kit†
Utilize the MagMAX Microbiome kit for faster and easier purification of high quality nucleic acids. With unique reagents specifically developed for microbiome research. The kit can lyse even the most difficult to lyse samples and pull pure total nucleic acid for your research.
MagMAX™ Wastewater Ultra Nucleic Acid Isolation Kit (with optional virus enrichment)†
The MagMAX Wastewater Ultra Nucleic Acid Isolation Kit enables efficient, high-throughput nucleic acid extraction from wastewater samples. The kit utilizes MagMAX magnetic-bead technology, ensuring reproducible recovery of high-quality nucleic acid compatible with a broad range of applications, such as RT- PCR and NGS. Optional enrichment for viral samples is also available.
MagMAX Viral/Pathogen II Nucleic Acid Isolation Kit (IVD)‡
The MagMAX Viral/Pathogen II Nucleic Acid Isolation Kit is designed to recover viral nucleic acids from nasopharyngeal swabs and viral RNA from saliva specimens. The kit utilizes MagMAX magnetic-bead technology, enabling reproducible recovery of high-quality nucleic acid and is compliant with In Vitro Diagnostic Regulation (EU) 2017/746.
*For In Vitro Diagnostic Use.
**RUO and IVD available.
†For research Use Only. Not for use in diagnostic procedures.
‡This product is approved under the In Vitro Diagnostic Regulations (IVDR) in the European Union.
Products are distributed in the U.S. and Europe so uses, applications, and availability of product in each country depend on local regulatory marketing authorization status. Clever Culture Systems is the legal manufacturer of the APAS® Independence. APAS® is a trademark of Clever Culture Systems. The APAS Independence is distributed in the U.S. and Europe by Thermo Fisher Scientific.
Style Sheet for Komodo Tabs
Style Sheet for Global Design System